4.4 Article

Evaluation of the Virus Counter (R) for rapid baculovirus quantitation

期刊

JOURNAL OF VIROLOGICAL METHODS
卷 171, 期 1, 页码 111-116

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jviromet.2010.10.010

关键词

Baculovirus; Plaque assay; Virus Counter; Recombinant protein; Virus quantitation

资金

  1. National Institutes of Health, National Institute of Allergy and Infectious Diseases(NIH/NIAID) [5 R44 AI068270-04]
  2. National Cancer Institute (NCI) [P30 CA125123-03]
  3. NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI068270] Funding Source: NIH RePORTER

向作者/读者索取更多资源

The utility of a new instrument for rapid virus quantitation, the Virus Counter, was evaluated in a blind study conducted at three sites. This instrument is a substantially improved version of the original academic research instrument described previously by Stoffel and Rowlen (2005a). The addition of hydrodynamic focusing, a self-contained fluidics system and customized software for system control and data analysis has resulted in a commercially viable and available design. Baculovirus samples were provided by Protein Sciences Corporation and blinded to InDevR and Baylor College of Medicine. Protein Sciences Corporation and Baylor College of Medicine analyzed the samples by plaque assay and InDevR analyzed the samples using the Virus Counter. Serial dilution of stock viruses into growth media and buffer allowed for comparison of measured versus intended concentrations. Direct log-scale comparison between pooled Virus Counter results and pooled plaque assay results indicated a linear relationship (slope = 1.1 +/- 0.2, R-2 = 0.86) with statistically significant Pearson correlation (r = 0.93, p < 0.001). (C) 2010 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据